预防性抗生素减少流产手术盆腔感染:AIMS随机对照试验研究方案
AIMS试验拟随机分配3400例流产手术女性(1:1),比较单剂口服多西环素400mg联合甲硝唑400mg与安慰剂,主要结局为术后2周盆腔感染,并评估成本效果。
要点
- 流产手术常见,感染后果严重,预防性抗生素或为简单可负担的干预。
- 拟随机3400例,术前约2小时单剂口服多西环素400mg+甲硝唑400mg或安慰剂。
- 主要结局为术后2周盆腔感染,同时评估抗生素使用、死亡、住院及成本效果。
核心结论
- 该试验将评估术前约2小时单剂口服多西环素400mg联合甲硝唑400mg能否降低流产手术后2周内盆腔感染发生率。
研究设计与样本
- 随机对照试验,计划随机3400例流产手术女性,每臂1700例,采用安全互联网设施按1:1比例随机分配。
- 分配对患者和医疗提供者隐藏,药物于手术前约2小时给予,手术按当地实践提供。
主要发现
- 研究方案阶段,未报告试验结果。
关键数值与推荐
- 干预为单剂口服多西环素400mg和甲硝唑400mg,对照为安慰剂。
- 主要结局为手术后2周盆腔感染,女性于2周时受邀到医院接受临床评估。
临床怎么用
- 若证实有效,预防性抗生素可能成为流产手术简单、可负担的干预以改善结局。
- 试验将进行经济评价以确定预防性抗生素是否具有成本效果。
局限性
- 本文为研究方案,尚无疗效与安全性结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The estimated annual global burden of miscarriage is 33 million out of 210 million pregnancies. Many women undergoing miscarriage have surgery to remove pregnancy tissues, resulting in miscarriage surgery being one of the most common operations performed in hospitals in low-income countries. Infection is a serious consequence and can result in serious illness and death. In low-income settings, the infection rate following miscarriage surgery has been reported to be high. Good quality evidence on the use of prophylactic antibiotics for surgical miscarriage management is not available. Given that miscarriage surgery is common, and infective complications are frequent and serious, prophylactic antibiotics may offer a simple and affordable intervention to improve outcomes. METHODS: Eligible patients will be approached once the diagnosis of miscarriage has been made according to local practice. Once informed consent has been given, participants will be randomly allocated using a secure internet facility (1:1 ratio) to a single dose of oral doxycycline (400 mg) and metronidazole (400 mg) or placebo. Allocation will be concealed to both the patient and the healthcare providers. A total of 3400 women will be randomised, 1700 in each arm. The medication will be given approximately 2 hours before surgery, which will be provided according to local practice. The primary outcome is pelvic infection 2 weeks after surgery. Women will be invited to the hospital for a clinical assessment at 2 weeks. Secondary outcomes include overall antibiotic use, individual components of the primary outcome, death, hospital admission, unplanned consultations, blood transfusion, vomiting, diarrhoea, adverse events, anaphylaxis and allergy, duration of clinical symptoms, and days before return to usual activities. An economic evaluation will be performed to determine if prophylactic antibiotics are cost-effective. DISCUSSION: This trial will assess whether a single dose of doxycycline (400 mg) and metronidazole (400 mg) taken orally 2 hours before miscarriage surgery can reduce the incidence of pelvic infection in women up to 2 weeks after miscarriage surgery. TRIAL REGISTRATION: Registered with the ISRCTN (international standard randomised controlled trial number) registry: ISRCTN 97143849 . (Registered on April 17, 2013).
引用
- Lissauer D, Wilson A, Daniels J, et al. Prophylactic antibiotics to reduce pelvic infection in women having miscarriage surgery - The AIMS (Antibiotics in Miscarriage Surgery) trial: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29685179. doi:10.1186/s13063-018-2598-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。